Startseite
Impressum
Datenschutz
 
 
  REVIEW
 

Prophylaxis of skeletal complications of bone metastases or multiple myeloma

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Discount contracts: consequences for patients

Autologous blood therapy ORTHOKIN: what´s new?

 
  IN BRIEF
 

Drospirenone-containing pill YAZ not additionally approved against acne

Pharmaceutical industry spends up to 91 million € per year for lobbying in the EU

 
  CURRENT ADR NETWORK REPORT
 

Lymphoma with natalizumab (TYSABRI)

Polyneuropathy and visual disturbance with dronedarone (MULTAQ)

 
  SIDE EFFECTS
 

Preventing accidental poisoning with opioid patches

Retinal detachment with gyrase inhibitors

 

© arznei-telegramm 5/2012